HDQLIFE and Neuro‐QoL Physical Function Measures: Responsiveness in Persons with Huntington's Disease

التفاصيل البيبلوغرافية
العنوان: HDQLIFE and Neuro‐QoL Physical Function Measures: Responsiveness in Persons with Huntington's Disease
المؤلفون: David Cella, Noelle E. Carlozzi, Michael K. McCormack, Nicholas R. Boileau, Rebecca E. Ready, Jennifer A. Miner, Kelvin L. Chou, Praveen Dayalu
المصدر: Mov Disord
بيانات النشر: Wiley, 2019.
سنة النشر: 2019
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, Neurological disorder, Disease, Physical function, Speech Disorders, Article, 03 medical and health sciences, 0302 clinical medicine, Physical medicine and rehabilitation, Quality of life, Huntington's disease, Swallowing, Surveys and Questionnaires, Humans, Medicine, Patient Reported Outcome Measures, Movement Disorders, business.industry, Chorea, Middle Aged, medicine.disease, Clinical trial, Cross-Sectional Studies, Huntington Disease, Treatment Outcome, 030104 developmental biology, Neurology, Quality of Life, Female, Self Report, Neurology (clinical), medicine.symptom, business, 030217 neurology & neurosurgery
الوصف: Background Huntington's disease (HD) is a neurological disorder that causes severe motor symptoms that adversely impact health-related quality of life. Patient-reported physical function outcome measures in HD have shown cross-sectional evidence of validity, but responsiveness has not yet been assessed. Objectives This study evaluates the responsiveness of the Huntington Disease Health-Related Quality of Life (HDQLIFE) and the Quality of Life in Neurological Disorders (Neuro-QoL) physical function measures in persons with HD. Methods A total of 347 participants completed baseline and at least 1 follow-up (12-month and 24-month) measure (HDQLIFE Chorea, HDQLIFE Swallowing Difficulties, HDQLIFE Speech Difficulties, Neuro-QoL Upper Extremity Function, and/or Neuro-QoL Lower Extremity Function). Of the participants that completed the baseline assessment, 338 (90.9%) completed the 12-month assessment, and 293 (78.8%) completed the 24-month assessment. Standardized response means and general linear models evaluated whether the physical function measures were responsive to self-reported and clinician-rated change over time. Results Small to moderate effect sizes for the standardized response means supported 12-month and 24-month responsiveness of the HDQLIFE and Neuro-QoL measures for those with either self-reported or clinician-rated declines in function. General linear models supported 12-month and 24-month responsiveness for all HRQOL measures relative to self-reported declines in health, but generally only 24-month responsiveness was supported relative to clinician-rated declines in function. Conclusions Longitudinal analyses indicate that the HDQLIFE and the Neuro-QoL physical function measures are sensitive to change over time in individuals with HD. Thus, these scales exhibit evidence of responsiveness and may be useful outcome measures in future clinical trials. © 2019 International Parkinson and Movement Disorder Society.
تدمد: 1531-8257
0885-3185
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1edb1ea32df3bf3234c08a8de716902Test
https://doi.org/10.1002/mds.27908Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....a1edb1ea32df3bf3234c08a8de716902
قاعدة البيانات: OpenAIRE